Related Experiment Video
Updated: Sep 10, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Long non‑coding RNA MEG3 knockdown alleviates hypoxia‑induced injury in rat cardiomyocytes via the miR‑325‑3p/TRPV4
Ya Zhou1, Xianguo Li2, Dong Zhao3
1Department of Cardiology, Jinxiang People's Hospital, Jining, Shandong 272200, P.R. China.
Abstract:
Acute myocardial infarction (AMI) is a common cardiac disease. Long non‑coding RNA maternally expressed 3 (MEG3) is associated with cellular processes in numerous complicated diseases, including AMI. However, the mechanism underlying MEG3 in myocardial hypoxia is not completely understood. The present study aimed to investigate the underlying mechanism of MEG3 in myocardial hypoxia. The expression levels of hypoxia‑inducible factor 1α (HIF1α), MEG3, microRNA (miR)‑325‑3p, and transient receptor potential cation channel subfamily V member 4 (TRPV4) in hypoxia‑treated H9c2 cells were detected via reverse transcription‑quantitative PCR. The protein expression levels of HIF1α, Bcl‑2, Bax, cleaved caspase‑3 and TRPV4 were detected via western blotting. Cell viability and apoptosis were assessed by performing an MTT assay and flow cytometry, respectively. Lactate dehydrogenase (LDH) release was monitored by conducting an LDH determination assay. The dual‑luciferase reporter assay was performed to verify the targeted relationship between miR‑325‑3p and MEG3 or TRPV4. The expression levels of MEG3 and TRPV4 were significantly increased, whereas miR‑325‑3p expression levels were significantly decreased in hypoxic H9c2 cells compared with normoxic H9c2 cells. In addition, miR‑325‑3p was downregulated by MEG3 compared with the vector group, and miR‑325‑3p targeted TRPV4 in hypoxia‑treated H9c2 cells. The results indicated that MEG3 knockdown attenuated hypoxia‑stimulated injury in H9c2 cells by regulating miR‑325‑3p. TRPV4 knockdown also mitigated hypoxia‑induced injury in H9c2 cells via miR‑325‑3p. Furthermore, compared with the vector group, MEG3 increased TRPV4 expression in hypoxia‑treated H9c2 cells by sponging miR‑325‑3p. Collectively, the results of the present study suggested that MEG3 modulated TRPV4 expression to aggravate hypoxia‑induced injury in rat cardiomyocytes by sponging miR‑325‑3p.
Insights
Long non-coding RNA MEG3 aggravates myocardial hypoxia injury by regulating miR-325-3p and TRPV4. MEG3 increases TRPV4 expression, worsening cell damage during hypoxia.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- Acute myocardial infarction (AMI) is a prevalent cardiac condition.
- Long non-coding RNA maternally expressed 3 (MEG3) plays a role in various diseases, including AMI.
- The precise mechanism of MEG3 in myocardial hypoxia remains unclear.
Purpose of the Study:
- To investigate the underlying mechanism of MEG3 in myocardial hypoxia.
- To explore the roles of MEG3, microRNA (miR)-325-3p, and transient receptor potential cation channel subfamily V member 4 (TRPV4) in hypoxia-induced cardiomyocyte injury.
Main Methods:
- Reverse transcription-quantitative PCR and western blotting to detect gene and protein expression.
- MTT assay, flow cytometry, and LDH assay to assess cell viability, apoptosis, and injury.
- Dual-luciferase reporter assay to confirm targeting relationships.
Main Results:
- MEG3 and TRPV4 expression increased, while miR-325-3p decreased in hypoxic H9c2 cells.
- MEG3 knockdown attenuated hypoxia-induced injury by regulating miR-325-3p.
- MEG3 increased TRPV4 expression by sponging miR-325-3p, aggravating hypoxia-induced injury.
Conclusions:
- MEG3 exacerbates hypoxia-induced injury in rat cardiomyocytes.
- MEG3 modulates TRPV4 expression via miR-325-3p sponging.
- Targeting the MEG3/miR-325-3p/TRPV4 axis may offer therapeutic potential for AMI.
More Related Videos
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi

